New Gavi Fund To Guarantee Global Market For COVID-19 Vaccines
Aim Is To Incentivize Investment And Ensure Equitable Access
Executive Summary
The latest global vaccines summit has seen the launch of a new mechanism designed to spur the development of new coronavirus vaccines and ensure they are made available, particularly in low- and middle-income countries.
You may also be interested in...
Coronavirus Notebook: Vaccine Pooling, WHO’s Law Lab & The Role Of The Llama
The coronavirus research field may be dominated by vaccines from the likes of Oxford University/AstraZeneca and Pfizer/BioNTech, but a lot of interesting work is being done elsewhere by smaller academic and commercial projects looking at the potential of various novel antibody therapies against COVID-19.
Coronavirus Notebook: Gavi Vaccines Move Under Fire, EU-US Step Up Regulatory Cooperation
In this latest Coronavirus Notebook, an international vaccine incentive mechanism comes under attack, researchers look at how to solve cold-chain coronavirus distribution problems in Africa, and Sanofi invests in a “world reference” vaccines R&D facility.
COVID-19 Vaccine Manufacturing: Moderna CEO Worries Most About Raw Materials
Moderna's Bencal and Merck Vaccine head Markels discuss the difficulties in scaling up manufacturing capacity for vaccine candidates at BIO plenary session; CEPI CEO says his organization can help facilitate pairing of vaccine development partners.